The changing trends of adult Hodgkin's disease in Saudi Arabia

Saudi Medical Journal

Volumn 24, Issue 6, 2003, Pages 617-622

  Al Diab, Abdulrahman I ^a,b   Siddiqui, Neelam ^a   Sogiawalla, Firoze F ^a   Fawzy, Essam M ^a  

^a KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

^b SECURITY FORCES HOSPITAL   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; CANCER STAGING; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE COURSE; FEMALE; FREQUENCY ANALYSIS; GENDER; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; QUESTIONNAIRE; RETROSPECTIVE STUDY; SAUDI ARABIA; SCLEROSIS; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; FEMALE; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SAUDI ARABIA; SEX DISTRIBUTION; STATISTICS, NONPARAMETRIC;

EID: 0037967583     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Glaser SL, Dorfman RF, Clarke CA. Expert review of the diagnosis and histologic classification of Hodgkin's disease in a population-based cancer registry. Cancer 2001; 92: 218-224.
2. Souhami R, Tobias J. Hodgkin's disease. Cancer and its management. 3rd ed. Oxford (UK): Blackwell Science; 1998. p. 426-444.
3. Deng F, Liu X, Tang W. A clinicopathological study of nodular lymphocyte predominance Hodgkin's disease. Zhonghua Xueyexue Zazhi 1999; 20: 239-241.
4. MacKenzie RG, Franssen E, Wong R, Sawka C, Berinstein N, Cowan DH et al. Risk-adapted therapy for clinical stage I-II Hodgkin's disease: 7-years results of radiotherapy alone for low-risk disease, and ABVD and radiotherapy for high-risk disease. Clin Oncol 2000; 12: 278-288.
5. Backstrand KH, Ng AK, Takvorian RW, Jones EL, Fisher DC, Molnar-Griffin BJ et al. Results of a prospective trial of mantle irradiation alone for selected patients with early-stage Hodgkin's disease. J Clin Oncol 2001; 19: 736-741.
6. Liao Z, Ha CS, Vlachaki MT, Hagemeister F, Cabinakkas F, Hess M et al. Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: Long-term follow-up and patterns of failure. Int J Rad Oncol Phys 2001; 50: 971-977.
7. Di Leonardo G, Torchio P, Pasqualoni E, Corrao G, Quaglino D. Incidence of malignant lymphoproliferative disease by stage and histological variants in central Italy: a population-based study 1982-1994. Eur Rev Med Pharmacol Sci 1998; 2: 65-74.
8. Hjalgrim H, Askling J, Pukkala E, Hansen S, Munksgaard L, Erisch M. Incidence of Hodgkin's disease in Nordic countries. Lancet 2001; 358: 297-298.
9. Chen Y, Zheng T, Chou M, Boyle P, Holford TR. The increase of Hodgkin's disease incidence among young adults. Experience in Connecticut, 1935-1992. Cancer 1997; 79: 2209-2218.
10. Chandi L, Kumar L, Kochupillai V, Dawar R, Singh R. Hodgkin's disease: a retrospective analysis of 15 years experience at a large referral center. Natl Med J Ind 1998; 11: 212-217.
11. Stirling G, Khalil AM, Nada GN, Saad AA, Raheem MA. Malignant neoplasms in Saudi Arabia. Cancer 1979; 44: 1543-1548.
12. Mughal TI, Robinson WA, Padmos MA. Adult Hodgkin's disease in Saudi Arabia. Eur J Surg Oncol 1985; 11: 41-45.
13. Al-Idrisi HY, Ibrahim EM. Hodgkin's disease in adults in Saudi Arabia. Clinical features, prognostic factors and an analysis of therapy. Outcome of combination chemotherapy only, for both localized and advanced disease. Int J Cancer 1991; 47: 822-826.
14. Koriech OM, Al-Kuhaymi R. Profile of cancer in Riyadh Armed Forces Hospital. Annals of Saudi Medicine 1994; 14: 187-194.
15. Ministry of Health. Cancer Incidence Report in Saudi Arabia 1994-1996 (Summary). National Cancer Registry (KSA): Ministry of Health; 1999. p. 70.
16. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the committee on Hodgkin's disease staging classification. Cancer Res 1971; 31: 1860-1861.
17. Riyat MS. Hodgkin's disease in Kenya. Cancer 1992; 69: 1047-1051.
18. Levy LM. Hodgkin's disease in black Zimbabweans. Cancer 1988; 61: 189-194.
19. Ramadas K, Sankaranarayanan R, Nair MK, Nair B, Padmanabhan TK. Adult Hodgkin's disease in Kerala. Cancer 1994; 73: 2213-2217.
20. Bamanikar S, Thunold S, Devi KRL, Bamanikar A. The pattern of malignant lymphoma in Oman. J Trop Med Hyg 1995; 98: 351-354.
21. Motawy SM, Omar YT. Hodgkin's disease in children in Kuwait. Cancer 1986; 57: 2255-2259.
22. McElwain TJ. Hodgkin's and non-Hodgkin's lymphomas. Br J Hosp Med 1984; 1: 10-20.
23. Cartwright R, McNally R, Roman E, Simpson J, Thomas J. Incidence and time trends in Hodgkin's disease: from parts of the United Kingdom (1984-1993). Leuk Lymphoma 1998; 31: 367-377.
24. Gelpi AP. Malignant lymphoma in the Saudi Arab. Cancer 1970; 25: 892-895.
25. Desforges JF, Rutherford CJ, Piro A. Hodgkin's disease. N Engl J Med 1979; 301: 1212-1221.
26. Glaser SL, Swartz WG. Time trends in Hodgkin's disease incidence. The role of diagnostic accuracy. Cancer 1990; 66: 2196-2204.
27. Tomasevic Z, Jelic S. Circulating immune complexes in advanced Hodgkin's disease: qualitative analysis and prognostic significance. Arch Immun Ther Exp 2000; 48: 195-200.
28. Al Bahar S, Pandita R, Al Bahar E, Al Muhana A, Al Yaseen N. Recent trends in the incidence of lymphomas in Kuwait. Neoplasma 1996; 43: 253-257.
29. Castella A, Joshi S, Raaschou T, Mason N. Pattern of malignant lymphoma in the United Arab Emirates - a histopathologic and immunologic study in 208 native patients. Acta Oncol 2001; 40: 660-664.
30. Kanavaros P, Stefanaki K, Vlachonikolis J, Eliopoulos G, Kakolyris S, Rontogianni D et al. Expression of p53, p21/waf1, bcl-2, bax, Rb and Ki67 proteins in Hodgkin's lymphomas. Histol Histopathol 2000; 15: 445-453.
31. Ohshima K, Akaiwa M, Umeshita R, Suzumia J, Izuhara K, Kikuchi M. Interleukin-13 and interleukin-13 receptor in Hodgkin's disease: possible autocrine mechanism and involvement in fibrosis. Histopathology 2001; 38: 368-375.
32. Weiss LM, Movabed LA, Warnke RA, Sklar J. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med 1989; 320: 502-506.
33. Wu TC, Mann RB, Charache P, Hayward D, Staal S, Lambe BC et al. Detection of EBV gene expression in Reed Sternberg cells of Hodgkin's disease. Int J Cancer 1990; 46: 801-804.
34. Kandil A, Bazarbashi S, Mourad WA. The correlation of Epstein-Barr virus expression and lymphocyte subsets with clinical presentation of nodular sclerosing Hodgkin disease. Cancer 2001; 91: 1957-1963.
35. Pallesen G, Hamilton-Dutoit SJ, Rowe M, Young LS. Expression of Epstein-Barr virus latent gene products in tumor cells of Hodgkin's disease. Lancet 1991; 337: 320-322.
36. Mourad W, Alsohaibani MO, Saddik M, Bazerbashi S. Epstein-Barr virus expression in Hodgkin's disease: correlation with histologic subtypes and T and B lymphocyte distribution. Annals of Saudi Medicine 1998; 18: 296-300.
37. Axdorph U, Porwit-Macdonald A, Sjoberg J, Grimfors G, Bjorkholm M. Epstein-Barr virus expression in Hodgkin's disease in relation to patient characteristics, serum factors and blood lymphocyte function. Br J Cancer 1999; 81: 1182-1187.
38. Khan G, Norton AJ, Slavin G. Epstein-Barr virus in Hodgkin's disease. Relation to age and subtype. Cancer 1993; 71: 3124-3129.
39. Takeuchi K, Morishita Y, Fukayama M, Mori S. Marked decrease in the Epstein-Barr virus positivity rate in nodular sclerosis subtype Hodgkin's disease in Tokyo: trend between 1955 and 1999. Br J Haematol 2001; 113: 429-431.
40. Clarke CA, Glaser SL, Dorfman RF, Mann R, Di-Giuseppe JA, Prehn AW et al. Epstein-Barr virus and survival after Hodgkin's disease in a population-based series of women. Cancer 2001; 91: 1579-1587.
41. Armstrong AA, Alexander FE, Paes RP, Morad NA, Gallagher A, Krajewski AS et al. Association of Epstein-Barr virus with pediatric Hodgkin's disease. Am J Pathol 1993; 142: 1683-1688.
42. Bosch PR, Alvaro NT, Balanza RR, Salvado MT, Martinez GS, Contreras BE et al. Hodgkin's disease. Etiopathogenic role of Epstein-Barr virus in Tarragona. Med Clin 2000; 114: 411-413.
43. Korbi S, Trimeche M, Sriha B, Yacoubi MT, Hmissa S, Mokni M et al. Epstein-Barr virus in Hodgkin's disease: the example of central Tunisia. Ann Pathol 2002; 22: 96-101.
44. Flavell KJ, Biddulph JP, Constandinou CM, Lowe D, Scott K, Crocker J et al. Variation in the frequency of Epstein-Barr virus-associated Hodgkin's disease with age. Leukemia 2000; 14: 748-753.
45. Jaffett RF. Viruses and Hodgkin's lymphoma. Ann Oncol 2002; 13: 23-29.